The Challenge of Imitating Nature

Principles of Tissue Engineering: Fourth Edition

Volumn , Issue , 2013, Pages 9-24

  Nerem, Robert M ^a   Schutte, Stacey C ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell technology; Cellular microenvironment; Engineered functional characteristics; Scaffolds; Translation

Indexed keywords

CELLS; CYTOLOGY; SCAFFOLDS; SCAFFOLDS (BIOLOGY); TISSUE; TRANSLATION (LANGUAGES);

ALLOGENEIC CELLS; CELL TECHNOLOGY; CELLULAR MICROENVIRONMENT; CLINICAL STUDY; FUNCTIONAL CHARACTERISTICS; IMMUNE ACCEPTANCE; MANUFACTURING PROCESS; MICROENVIRONMENTS;

CELL ENGINEERING;

EID: 84903223496     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398358-9.00002-1     Document Type: Chapter

References (81)

1. Badylak S.F., Nerem R.M. Progress in tissue engineering and regenerative medicine. Proc National Academy of Sciences USA 2010, 107(8):3285-3286.
2. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260(5110):920-926.
3. Nerem R.M., Sambanis A. Tissue engineering: from biology to biological substitutes. Tissue Engineering 1995, 1(1):3-13.
4. Carrel A., Lindbergh C. The culture of organs 1938, New York: Paul B. Hoeber, Inc., New York, Harper Brothers.
5. Nerem R.M. Tissue Engineering: The hope, the hype, and the future. Tissue Engineering 2006, 12(5):1143-1150.
6. Nerem R.M. Cell-based therapies: from basic biology to replacement, repair, and regeneration. Biomaterials 2007, 28(34):5047-5077.
7. Lysaght M.J., Jaklenec A., Deweerd E. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng 2008, 14(2):302-315.
8. Nerem R.M. Regenerative Medicine: The Emergence of an Industry. Journal of the Royal Society Interface 2010, 7(Suppl 6):S771-S775.
9. Jaklenec A., Sharp A., Deweerd E., Sherwin A., Langer R. Progress in the tissue engineering and stem cell industry: are we there yet?. Tissue Engineering Part B 2012, 18(3):155-166.
10. NSF Workshop, UCLA Symposia on Molecular and Cellular Biology 1998, Alan R Liss, Inc. R. Skalak, C. Fox (Eds.).
11. Galletti P.M., Aebischer P., Lysaght M.J. The dawn of biotechnology in artificial organs. Am Soc Artif Intern Organs 1995, 41(1):49-57.
12. Yannas I.V., Burke J.F., Orgill D.P., Skrabut E.M. Wound tissue can utilize a polymetric template to synthesize a functional extension of skin. Science 1982, 215(4529):174-176.
13. Badylak S., Arnoczky S., Plouher P., Haut R., Mendenhall V., Clarke R., et al. Naturally occurring extracellular matrix as a scaffold for musculoskeletal repair. Clin Ortho Related Res 1999, 367:S333-343.
14. Lindberg K., Badylak S. Small intestine submuscosa (SIS): a bioscaffold supporting in vitro primary epidermal cell differentiation and synthesis of basement membrane proteins. Burns 2001, 27(3):254-256.
15. Baddour J.A., Sousounis K., Panagiotis P.A. Organ repair and regeneration: an overview. Birth Defects Research (Part C) 2012, 96(1):1-29.
16. Chuong C.-M., Randall V.A., Widelitz R.B., Wu P., Jiang T.-X. Physiological regeneration of skin appendages and implications for regenerative medicine. Physiology 2012, 27(1):61-72.
17. Yannas I.V. Similarities and differences between induced organ regeneration in adults and early fetal regeneration. J. R Soc Interfact 2005, 2(5):403-417.
18. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science 1997, 276(5309):60-66.
19. Gilgenkrantz H. Collin de l'Hortet, A. New insights into liver regeneration. Clin Res Hepatol Gastroenterol 2011, 35(10):623-629.
20. Mortensen K.E., Revhaug A. Liver regeneration in surgical animal models - a historical perspective and clinical implications. Eur Surg Res 2011, 46(1):1-18.
21. Salamonsen L.A. Tissue injury and repair in the female human reproductive tract. Reproduction 2003, 125(3):301-311.
22. Garry R., Hart R., Karthigasu K.A., Burke C. A re-appraisal of the morphological changes within the endometrium during menstruation: a hysteroscopic, histological and scanning electron microscopic study. Human Reproduction 2009, 24(6):1393-1401.
23. Nair A.R., Taylor H.S. The mechanism of menstruation. Amenorrhea: A Case-Based, Clinical Guide 2010, 21-34. Humana Press, New York. N.F. Santoro, G. Neal-Perry (Eds.).
24. Salamonsen L.A., Giudice L.C. The curse: a 21st century perspective of models of its molecular basis. Endocrinology 2010, 151(9):4092-4095.
25. Stegemann J.O., Nerem R.M. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three- dimensional culture. Experimental Cell Research 2003, 283(2):146-155.
26. Bentin-Ley U., Pedersen B., Lindenberg S., Larsen J.F., Hamberger L., Horn T. Isolation and culture of human endometrial cells in a three-dimensional culture system. J Reprod Fertil 1994, 101(2):327-332.
27. Park D.W., Choi D.S., Ryu H.-S., Kwon H.C., Jao H., Min C.K. A well-defined in vitro three-dimensional culture of human endometrium and its applicability to endometrial cancer. Cancer Letters 2003, 195(2):185-192.
28. Mardon H., Grewal S., Mills K. Experimental models for investigating implantation of the human embryo. Semin Reprod Med 2007, 25(6):410-417.
29. Schutte S.C., Taylor R.N. A tissue engineered human endometrial stroma that responds to cues for secretory differentiation, decidualization and menstruation. Fertil Steril 2012, 97(4):997-1003.
30. Schenke-Layland K., Nerem R.M. Commentary: in vitro human tissue models-moving towards personalized medicine. Advanced Drug Delivery Reviews 2011, 63(4-5):195-196.
31. Huh D., Matthews B.D., Mammoto A., Montoya-Zavala M., Hsin H.Y., Ingber D.E. Reconstituting organ-level lung functions on a chip. Science 2010, 328(5986):1662-1668.
32. Kim H.J., Huh D., Hamilton G., Ingber D.E. Human gut-on-a-chip inhabited by microbial flora that experience intestinal peristalsis-like motions and flow. Lab on a chip 2012, 12(12):2165-2174.
33. Aznaje F. Computational discrete models of tissue growth and regeneration. Briefings in Bioinformatics 2010, 12(1):64-77.
34. Mogilner A., Allard J., Wollman R. Cell polarity: quantitative modeling as a tool in cell biology. Science 2012, 336(6078):175-179.
35. Peirce S.M. Computational and mathematical modeling of angiogenesis. Microcirculation 2008, 15(8):739-751.
36. Wiesner T.F., Berk B.C., Nerem R.M. A mathematical model of cytosolic calcium dynamics in human umbilical vein endothelial cells. American Journal of Physiology: Cell Physiology 1996, 270(5 Pt 1):C1556-C1569.
37. Weisner T.F., Berk B.C., Nerem R.M. A mathematical model of cytosolic free calcium response in endothelial cells to fluid shear stress. Proc of the Natl Acad of Sci USA 1997, 94(8):3726-3731.
38. Parenteau N. Skin: The first tissue-engineered products-The Organogenesis story. Sci Am 1999, 280(4):83-84.
39. Naughton G. Skin: The first tissue-engineered products-The Advanced Tissue Sciences story. Sci Am 1999, 280(4):84-85.
40. Solter D., Gearhart J. Putting stem cells to work. Science 1999, 283(5407):1468-1470.
41. Vogel G. Harnessing the power of stem cells. Science 1999, 283(5407):1432-1434.
42. Vats A., Bielby R.C., Tolley N.S., Nerem R.M., Polak J.M. Stem Cells. Lancet 2005, 366(9485):592-602.
43. Thomson J.A., Itskovitaz-Elder J., Shapiro S.S., Waknitz M.Z., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147.
44. Shamblott M.J., Axelman J., Wang S., Bugg E.M., Littlefield J.W., Donovanm Blummenthal P.J., et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998, 95(23):13726-13731.
45. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
46. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichiska T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
47. Yamanaka S. A fresh look at iPS cells. Cell 2009, 137(1):13-17.
48. Saha K., Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 2009, 5(6):584-595.
49. Coppi P., Bartsch G., Siddiqui M.M.m, et al. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology 2007, 25(1):100-106.
50. Broxmeyer H.E., Douglas G.W., Hangoc G., Cooper S., Bard J., English D., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989, 86(10):3828-3832.
51. Cheung C., Bernardo A.S., Trotter M.W., Pedersen R.A., Sinha S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nature Biotech 2012, 30(2):165-173.
52. Cima L.G., Langer R., Vacanti J.P. Polymers for tissue and organ culture. Bioact Compat Polym 1991, 6(3):232-239.
53. Bell E., Ivarsson B., Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979, 76(3):1274-1278.
54. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231(4736):397-399.
55. Auger P.A., Lopez Valle C.A., Guignard R., Tremblay N., Noel B., Goulet F., et al. Skin equivalent produced with human collagen. In vitro Cell Dcv Biol 1995, 31:432-439.
56. Heureux N.L., Paquet S., Labbe R., Germain L., Auger R.A. A completely biological tissue-engineered human blood vessel. FASEBJ 1998, 12(1):47-56.
57. McAllister T.N., Maruszewski M., Garrido S.A., Wystrychowski W., Dusserre N., Marini A., et al. Effectiveness of hemodialysis access with an autologous tissue-engineered vascular graft: a multicenter cohort study. Lancet 2009, (9673):1440-1446.
58. McAllister T.N., Maruszewski M., Garrido S.A., Wystrychowski W., Dusserre N., Marini A., et al. Effectiveness of a hemodialysis access with an autologous tissue-engineered vascular graft: a multicenter cohort study. Lancet 2009, 373(9673):1400-1447.
59. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 2009, 5(1):1-13.
60. Badylak S.F., Taylor D., Uygun K. Whole organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Engineering 2011, 13:27-53.
61. Badylak S.F., Weiss D.T., Caplan A., Macchiarini P. Engineered whole organs and complex tissues. Lancet 2012, 379(9819):943-952.
62. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14(2):213-221.
63. Ott H.C., Clippinger B., Conrad C., Schuetz C., Pomerantseva I., Ikonomou L., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010, 16(8):927-933.
64. Baptista P.M., Siddiqui M.M., Lozier G., Rodriguez S.R., Atala A., Soker S. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011, 53(2):604-617.
65. Dahl S.L., Kypson A.P., J.H.Lawson J.L., Blum J.T., Strader Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3(68):1-11.
66. Campbell G.R., Turnbull G., Xiang L., Haines M., Armstrong S., Rolfe B.E., et al. The peritoneal cavity as a bioreactor for tissue engineering visceral organs: bladder, uterus, and vas deferens. J Tissue Eng Regen Med 2008, 2(1):50-60.
67. Freed L.E., Vunjak G., Langer R. Cultivation of cell-polymer cartilage implants in bioreactors. J Cell Biochem 1993, 51(3):257-264.
68. Seliktar D., Black R.A., Nerem R.M. Use of a cyclic strain bioreactor to precondition a tissue-engineered blood vessel substitute. Ann Biomed Eng 1998, 26(Suppl. 1). S-137.
69. Saini S., Wick T.M. Concentric cylinder bioreactor for production of tissue engineered cartilage: effect of seeding density and hydrodynamic loading on construct development. Biotechnology Progress 2003, 19(2):510-521.
70. Sucosky P., Osorio D.F., Brown J.B., Neitzel G.P. Fluid mechanics of a spinner-flask bioreactor. Biotech and Bioengr 2004, 85(1):34-46.
71. Getts D.R., Shankar S., Chastain E.M.L., Martin A., Getts M.T., Wood K., et al. Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy 2011, 3(7):853-870.
72. Goldstein D.R. Inflammation and transplantation tolerance. Semin Immunopathol 2011, 33(2):111-115.
73. Larsen C.P., Elwood E.T., Alexander D.Z., Ritchie S.C., Hendrix R., Tucker-Burden C., et al. Long-term acceptance of skin and cardiac allografts by blockade of the CD40 and CD28 pathways. Nature (London) 1996, 381(6581):434-438.
74. Mason C., Manzotti M. Regenerative medicine cell therapies: number of units manufactured and patients treated between 1988 and 2010. Regen Med 2010, 5(3):307-313.
75. Brandenberger R., Burger S., Campbell A., Fong T., Lapinskas E., Rowley J.A. Cell therapy bioprocessing: Integrating process and product development for the next generation of biotherapies. BioProcess International 2011, 9:30-37.
76. Kirouac D.C., Zandstra P.W. The systematic production of cells for the cell therapy. Cell Stem Cell 2008, 3(4):369-381.
77. Rowley J.A. Developing cell therapy biomanufacturing processes. CEP SBE Supplement Stem Cell Engineering 2010, 11(11):50-55.
78. Carmen J., Burger S.R., McCaman M., Rowley J.A. Developing assays to address identity, potency, purity, and safety: cell characterization in cell therapy process development. Regen Med 2012, 1(1):85-100.
79. Brittberg M., Lindlah A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331(14):889-895.
80. Simpson D., Liu H., Hwang T., Fan M., Nerem R.M., Dudley S.C. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 2007, 25(9):2350-2357.
81. National Research Council A new biology for the 21st century 2009, The National Academies Press, Washington, D.C.